MedPath

FLUOROPHARMA, INC.

FLUOROPHARMA, INC. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2003-01-01
Employees
11
Market Cap
-
Website
http://www.fluoropharma.com

Clinical Trials

4

Active:0
Completed:3

Trial Phases

2 Phases

Phase 1:2
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 2
2 (50.0%)

BFPET for Regional Myocardial Perfusion Imaging

Phase 2
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2014-09-30
Last Posted Date
2018-08-01
Lead Sponsor
Fluoropharma, Inc.
Target Recruit Count
40
Registration Number
NCT02252783
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

CardioPET as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects

Phase 2
Completed
Conditions
Coronary Artery Disease
Interventions
Drug: CardioPET™
First Posted Date
2013-04-09
Last Posted Date
2017-03-10
Lead Sponsor
Fluoropharma, Inc.
Target Recruit Count
34
Registration Number
NCT01826773
Locations
🇧🇪

Dienst Nucleaire Geneeskunde, OLV Ziekenhuis Aalst, Aalst, Belgium

🇧🇪

Departement de Cardiologie, CU Saint-Luc, Bruxelles, Belgium

🇧🇪

Service de Medicine Nucleaire, CHU Erasme, Bruxelles, Belgium

and more 2 locations

A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET

Phase 1
Completed
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2008-08-13
Last Posted Date
2013-06-10
Lead Sponsor
Fluoropharma, Inc.
Target Recruit Count
12
Registration Number
NCT00733460
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease

Phase 1
Completed
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2006-12-20
Last Posted Date
2013-06-12
Lead Sponsor
Fluoropharma, Inc.
Target Recruit Count
21
Registration Number
NCT00413647
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.